latest news releases from the newsroom
OXiGENE Reports Second Quarter 2008 Results
WALTHAM, Mass., Aug. 4, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter ended June 30, 2008 and presented an update on recent clinical and corporate progress.
Kahn Swick & Foti, LLC
Investor Alert: KGS Urges SemGroup Energy Partners, L.P. Non-U.S. Shareholders, and Others With Losses Greater Than $100,000 That They Have Until September 19, 2008 to File Lead Plaintiff Application in Securities Fraud Class Action Lawsuit -- SGLP
NEW ORLEANS, Aug. 2, 2008 (PRIME NEWSWIRE) -- Kahn Gauthier Swick, LLC ("KGS") notifies non-U.S. shareholders and others with losses greater than $100,000 that September 19, 2008 is the deadline to file lead plaintiff applications in a securities fraud class action pending in the United States District Court for the Southern District of New York, on behalf of shareholders who purchased the common stock of SemGroup Energy Partners, L.P. ("SGLP" or the "Company") (Nasdaq:SGLP) between February 20, 2008 and July 17, 2008, inclusive (the "Class Period"). No class has yet been certified in this action.